CRBU
Caribou Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.57
+0.00%Margins
Gross margin
-129.7%
EBITDA margin
-1037.4%
EBIT margin
-1090.9%
Net margin
-1030.4%
FCF margin
-954.2%
-105.4%
Return on equity
-72.4%
Return on assets
-87.7%
Return on invested capital
0.07x
Asset turnover
-$95.8M
Cash from operations
$1.05
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026